Data / New clinical trials / Lupus Erythematosus, Systemic

Lupus Erythematosus, Systemic trials: 279 new since Nov 2024

Name: New Lupus Erythematosus, Systemic clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Lupus Erythematosus, Systemic clinical trials: 279 rows for $13.95, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 10 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/lupus-erythematosus-systemic, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 6, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

279 clinical studies in Lupus Erythematosus, Systemic were first posted on ClinicalTrials.gov from November 12, 2024 to November 6, 2026; 118 have an industry sponsor and 227 are recruiting or about to. The newest, NCT07923747, was posted on November 6, 2026: An Ascending Dose Study of DKB903 in Participants With Rheumatoid Arthritis (RA) and Participants With... (Novartis Pharmaceuticals).

The request: Every new Lupus Erythematosus, Systemic clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

279New trials
118Industry sponsored
227Recruiting or not yet
November 6, 2026Latest posted

Newest trials

The newest 100 of 279, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 6, 2026	NCT07923747	An Ascending Dose Study of DKB903 in Participants With Rheumatoid Arthritis (RA) and Participants With Systemic Lupus Erythematosus (SLE)	Novartis Pharmaceuticals	Phase 1	Not yet recruiting	Rheumatoid Arthritis and Systemic Lupus Erythematosus	90		clinicaltrials.gov
November 3, 2026	NCT07913919	Effect of Anifrolumab on Arterial Inflammation in Systemic Lupus Erythematosus Study	University of Cambridge	Not applicable	Recruiting	Systemic Lupus Erythematosus, Atherosclerosis Generalized	15	United Kingdom	clinicaltrials.gov
October 30, 2026	NCT07906145	A Phase 1 Study of QLS2416 Injection in Participants With Autoimmune Diseases	Shanghai Qilu Pharmaceutical Research and Development Center LTD	Phase 1	Not yet recruiting	Systemic Lupus Erythematosus, Rheumatoid Arthritis (RA), Primary Sjögren's Syndrome (pSS), Systemic Sclerosis (SSc)	76		clinicaltrials.gov
October 29, 2026	NCT07902622	Pakistan Arthritis and Connective Tissue Disease Network - Systemic Lupus Erythematosus	Foundation University Islamabad	Observational	Recruiting	SLE - Systemic Lupus Erythematosus	3,000	Pakistan	clinicaltrials.gov
October 28, 2026	NCT07901764	MYTP01 for Immune-Mediated Diseases	Zhejiang Provincial People's Hospital	Not applicable	Not yet recruiting	IgA Nephropathy, Kidney Transplant Recipients, Lupus Nephritis, Primary Membranous Nephropathy, ANCA-associated...	160	China	clinicaltrials.gov
October 28, 2026	NCT07901634	Association of Inflammatory Biomarkers and Ferritin With Severity of Pediatric Systemic Lupus Erythematosus Patients	Desy Wulandari	Observational	Not yet recruiting	Lupus Erythematosus, Systemic	62		clinicaltrials.gov
October 23, 2026	NCT07892651	MENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT)	Axiom Bioregistry	Observational	Not yet recruiting	Antiphospholipid (aPL)-Positive, Rheumatic Arthritis, Celiac Disease, Focal Segmental Glomerulosclerosis (FSGS)...	5,000	Jordan	clinicaltrials.gov
October 14, 2026	NCT07873931	A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases	Bristol-Myers Squibb	Phase 1	Not yet recruiting	Systemic Lupus Erythematosus, Sjögren's Disease, Rheumatoid Arthritis, Idiopathic Inflammatory Myopathies, Systemic...	60	Belgium, France, Germany, Netherlands, Poland, United States	clinicaltrials.gov
October 9, 2026	NCT07868289	Effectiveness of Resonance Frequency Breathing Exercises in Patients With Systemic Lupus Erythematosus and Central Sensitization	Istanbul University - Cerrahpasa	Not applicable	Not yet recruiting	Systemic Lupus Erythematosus (SLE), Central Sensitization, Chronic Pain	38	Turkey (Türkiye)	clinicaltrials.gov
October 5, 2026	NCT07858461	Subclinical Gastrointestinal Involvement in Juvenile Systemic Lupus Erythematosus	Assiut University	Observational	Not yet recruiting	Systemic Lupus Erythematosus, Gastrointestinal Diseases	60		clinicaltrials.gov
October 2, 2026	NCT07855302	CD19 CAR-T Therapy for Refractory Childhood-Onset Systemic Lupus Erythematosus	Seoul National University Hospital	Phase 1	Recruiting	Childhood-Onset Systemic Lupus Erythematosus, Refractory SLE, CD19 CAR-T Cell Therapy	8	South Korea	clinicaltrials.gov
September 28, 2026	NCT07844200	The Primary Objective of the Trial is to Evaluate the Effect of the Addition of Belantamab Mafodotin to Standard of Care Therapy on the...	Medical Association for the Study of Cancer Biology and Treatment	Phase 2	Not yet recruiting	SLE - Systemic Lupus Erythematosus	12		clinicaltrials.gov
September 25, 2026	NCT07840573	Feasibility and Performance of a Structured Video Telemedicine Program in Patients With Systemic Lupus Erythematous	Baylor College of Medicine	Not applicable	Completed	Systemic Lupus Erythematosus	100	United States	clinicaltrials.gov
September 25, 2026	NCT07840287	A Long-Term Extension (LTE) Study Of Enpatoran In Cutaneous Manifestations Of Lupus With Or Without Systemic Disease [Elowen-LTE]	EMD Serono Research & Development Institute, Inc.	Phase 3	Not yet recruiting	Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE)	404	Germany, United States	clinicaltrials.gov
September 23, 2026	NCT07837544	Diastolic Dysfunction and Inflammatory Biomarkers in Lupus Nephritis	Assiut University	Observational	Not yet recruiting	Lupus Nephritis, Diastolic Dysfunction, Systemic Lupus Erythematosus, Heart Failure, Diastolic	90		clinicaltrials.gov
September 21, 2026	NCT07829614	F182112 Phase Ib Clinical Study for the Treatment of Patients With Systemic Lupus Erythematosus	Shandong New Time Pharmaceutical Co., LTD	Phase 1	Recruiting	Systemic Lupus Erythematosus (SLE)	64	China	clinicaltrials.gov
September 21, 2026	NCT07829497	Pain Phenotyping of Rheumatic Diseases - An Observational Study	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	Observational	Recruiting	Rheumatic Diseases, Lupus Erythematosus, Systemic, Lupus Vasculitis, Central Nervous System, Arthritis...	225	United States	clinicaltrials.gov
September 16, 2026	NCT07823478	HEALTH Home Urinalysis Testing	NYU Langone Health	Not applicable	Recruiting	Systemic Lupus Erythematosus	160	United States	clinicaltrials.gov
September 9, 2026	NCT07810569	Ocular Surface Changes and Meibomian Gland Dysfunction in Rheumatologic Patients	Assiut University	Observational	Not yet recruiting	Meibomian Gland Dysfunction, Dry Eye Syndromes, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjogren's Syndrome...	150		clinicaltrials.gov
September 8, 2026	NCT07805863	Serum MPO-DNA Complexes as a Biomarker of Disease Activity in Systemic Lupus Erythematosus	Assiut University	Observational	Not yet recruiting	Systemic Lupus Erythematosus, Lupus Nephritis	90		clinicaltrials.gov
September 2, 2026	NCT07800871	FT839 in Autoimmune Diseases	Fate Therapeutics	Phase 1/2	Recruiting	ANCA-Associated Vasculitis (AAV), Idiopathic Inflammatory Myositis (IIM), Rheumatoid Arthritis (RA), Systemic Lupus...	446	United States	clinicaltrials.gov
September 2, 2026	NCT07799116	Study to Evaluate the Safety and Preliminary Efficacy of CD19 CAR-T Cell Therapy (TranspoCART19) in Patients With Refractory Lupus Nephritis	Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz	Phase 1/2	Recruiting	Lupus Nephritis, Lupus Nephritis (LN)	10	Spain	clinicaltrials.gov
August 27, 2026	NCT07791199	Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study Completers	Bristol-Myers Squibb	Phase 3	Not yet recruiting	Systemic Lupus Erythematosus, Sjögren's Disease, Psoriasis, Psoriatic Arthritis	2,300		clinicaltrials.gov
August 24, 2026	NCT07782450	A Study to Learn About a Medicine Called PF-08154225 in Participants With Autoimmune Diseases	Pfizer	Phase 1/2	Not yet recruiting	Systemic Lupus Erythematosus, Rheumatoid Arthritis, Idiopathic Inflammatory Myositis, Systemic Sclerosis	54		clinicaltrials.gov
August 21, 2026	NCT07780045	SII and SIRI as Prognostic Biomarkers in Lupus Nephritis	Assiut University	Observational	Not yet recruiting	Lupus Nephritis, Systemic Lupus Erythematosus, Kidney Diseases	100		clinicaltrials.gov
August 21, 2026	NCT07778446	A Study to Test CRT-402 in Refractory Autoimmune Disease	Myeloid Therapeutics	Phase 1/2	Recruiting	Autoimmune Diseases, Systemic Lupus Erythematosus, Systemic Scleroderma, Myositis	34	Australia	clinicaltrials.gov
August 20, 2026	NCT07775612	Pain-Sleep in Rheumatic Disease	The Hospital for Sick Children	Not applicable	Not yet recruiting	Rheumatic Diseases, Arthritis, Lupus, Lupus Arthritis, Systemic Lupus Erythematosus, JIA, Dermatomyositis, Vasculitis...	43		clinicaltrials.gov
August 13, 2026	NCT07763821	Clinical Utility of Serum Ribonuclease 1(RNASE1) as a Biomarker of Lupus Nephritis.	Assiut University	Observational	Not yet recruiting	System Lupus Erythematosus(SLE)	128		clinicaltrials.gov
August 12, 2026	NCT07760480	Assessing Residual Inflammation and Macrophage Presence in Lupus Nephritis After 3 Months of Intensified Treatment With Prednisolone...	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	Phase 4	Recruiting	Lupus Nephritis, Systemic Lupus Erythematosus (SLE)	55	Netherlands	clinicaltrials.gov
August 12, 2026	NCT07760155	A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Systemic Lupus Erythematosus	Shanghai Escugen Biotechnology Co., Ltd	Phase 2	Not yet recruiting	Systemic Lupus Erythematosus (SLE)	40	China	clinicaltrials.gov
August 7, 2026	NCT07751848	A Study of Outcomes in Chinese Patients Treated With Anifrolumab Who Have Active Mod-severe Systemic Lupus Erythematosus	AstraZeneca	Phase 3	Recruiting	Lupus Erythematosus, Systemic	417	China	clinicaltrials.gov
August 7, 2026	NCT07751315	A Study of QLS2404 Injection in Healthy Participants and Participants With Rheumatic Autoimmune Diseases	Qilu Pharmaceutical Co., Ltd.	Phase 1	Not yet recruiting	Systemic Lupus Erythematosus, Primary Sjögren's Syndrome	64	China	clinicaltrials.gov
August 5, 2026	NCT07748156	SNC116 Therapy for Refractory Systemic Lupus Erythematosus	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	Early phase 1	Not yet recruiting	Systemic Lupus Erythematosus	28	China	clinicaltrials.gov
July 28, 2026	NCT07732309	A Study of ATG-201 in Adult Participants With Autoimmune Diseases	Antengene Biologics Limited	Phase 1	Recruiting	Systemic Lupus Erythematosus, Systemic Sclerosis (SSc), Sjogren's Disease, Autoimmune Diseases	149	China	clinicaltrials.gov
July 28, 2026	NCT07729826	C-CAR168, an Autologous Anti-CD20/BCMA Chimeric Antigen Receptor T-Cell Therapy, in Participants With Lupus Nephritis Refractory to...	AbelZeta Inc.	Phase 2	Not yet recruiting	Lupus Nephritis (LN), Systemic Lupus Erythematosus (SLE), Autoimmune Diseases	50		clinicaltrials.gov
July 23, 2026	NCT07721363	Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous Nephropathy: a Phase II Trial	Assistance Publique - Hôpitaux de Paris	Phase 2	Not yet recruiting	Lupus Nephritis, Membranous Nephropathy	65	France	clinicaltrials.gov
July 23, 2026	NCT07721324	Effect of Melatonin Administration on Systemic Lupus Erythematosus Patients	Ain Shams University	Phase 2/3	Not yet recruiting	Therapy, Treatment	64	Egypt	clinicaltrials.gov
July 22, 2026	NCT07720310	Anti-CD19 CAR-T Cell Therapy for Patients With Refractory Systemic Lupus Erythematosus	N.N. Alexandrov National Cancer Centre	Observational	Enrolling by invitation	System Lupus Erythematosus(SLE)	12	Belarus	clinicaltrials.gov
July 22, 2026	NCT07719140	Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial)	Peking Union Medical College Hospital	Phase 4	Recruiting	Childhood-onset Systemic Lupus Erythematosus, Lupus Nephritis (LN)	198	China	clinicaltrials.gov
July 7, 2026	NCT07688980	Study to Characterise Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Anifrolumab Administered Subcutaneously (SC) or...	AstraZeneca	Phase 1	Not yet recruiting	Systemic Lupus Erythematosus	92		clinicaltrials.gov
July 1, 2026	NCT07680010	Modeling the Early Stages of Autoimmunity Through the Study of Immunological Thrombocytopenic Purpura and Juvenile Lupus	University Hospital, Bordeaux	Not applicable	Not yet recruiting	Immune Thrombocytopenic Purpura ( ITP ), Systemic Lupus Erythematosus (SLE)	105	France	clinicaltrials.gov
July 1, 2026	NCT07679776	Study on Early Visual Dysfunction in Patients With Systemic Lupus Erythematosus	The First Affiliated Hospital of Anhui Medical University	Observational	Enrolling by invitation	Systemic Lupus Erythematosus (SLE), Visual Function	100	China	clinicaltrials.gov
July 1, 2026	NCT07678203	Dapagliflozin to Reduce the Decline in Renal Function in Patients Newly Diagnosed With Lupus Nephritis	Hospital Civil Juan I. Menchaca	Phase 1/2	Active not recruiting	Lupus Nephritis (LN), Chronic Kidney Disease, SGLT 2 Inhibitors, Systemic Lupus Erythematosus	30	Mexico	clinicaltrials.gov
June 30, 2026	NCT07676266	A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy	The Affiliated Hospital of Qingdao University	Phase 1	Not yet recruiting	Multiple Sclerosis (MS), Myasthenia Gravis (MG), Neuromyelitis Optica Spectrum Disorder, Systemic Lupus Erythematosus...	18	China	clinicaltrials.gov
June 29, 2026	NCT07674147	RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases	The Children's Hospital of Zhejiang University School of Medicine	Early phase 1	Not yet recruiting	Autoimmune Diseases, SLE - Systemic Lupus Erythematosus, SSc-Systemic Sclerosis, IIM- Idiopathic Inflammatory...	30	China	clinicaltrials.gov
June 24, 2026	NCT07666711	Biomarker Development for Autoimmune Disorders Involving the Kidneys	Oslo University Hospital	Observational	Recruiting	Lupus Nephritis, Systemic Lupus Erythematosus	500	Norway	clinicaltrials.gov
June 22, 2026	NCT07659704	CD19-Directed CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus	University of Sao Paulo	Phase 1/2	Not yet recruiting	Lupus Erythematosus, Systemic	16	Brazil	clinicaltrials.gov
June 18, 2026	NCT07657793	Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia	Chinese SLE Treatment And Research Group	Phase 2/3	Recruiting	Systemic Lupus Erythematosus, Immune Thrombocytopenia	164	China	clinicaltrials.gov
June 16, 2026	NCT07649265	A Trial in Healthy Adult Participants and Adults With Autoimmune Diseases to Test How HBM7020 is Tolerated and How it Behaves in the Body	Otsuka Pharmaceutical Development & Commercialization, Inc.	Phase 1	Recruiting	Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis, Sjögren's Disease	63	Australia	clinicaltrials.gov
June 9, 2026	NCT07636044	Reduced Vaccine Response to HZ/su in SLE	Seoul National University Hospital	Observational	Recruiting	Vaccine Reaction, Zoster, Systemic Lupus Erythematosus	80	South Korea	clinicaltrials.gov
June 5, 2026	NCT07630714	A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years...	AstraZeneca	Phase 2	Recruiting	Systemic Lupus Erythematosus	24	Australia, Belgium, Chile, Israel, Japan, Netherlands, Peru, Philippines...	clinicaltrials.gov
June 5, 2026	NCT07629596	Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of Arnovie101, an mRNA-LNP-Based In Vivo CAR-T Therapy, for the Treatment of B...	Circunited BioPharma (Shenzhen) Co., Ltd.	Early phase 1	Recruiting	Systemic Lupus Erythematosus, Autoimmune Hemolytic Anemia (AIHA)	5	China	clinicaltrials.gov
June 5, 2026	NCT07629583	To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis	Genentech, Inc.	Phase 1	Recruiting	Lupus Erythematosus, Systemic	46	Australia, Brazil, China, France, Italy, Spain	clinicaltrials.gov
June 3, 2026	NCT07622251	The Effect of Exercise on Cognitive Functions in Individuals With Systemic Lupus Erythematosus	Istanbul Galata University	Not applicable	Not yet recruiting	System Lupus Erythematosus(SLE)	38	Turkey (Türkiye)	clinicaltrials.gov
June 1, 2026	NCT07617740	IASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE)	Peking University People's Hospital	Early phase 1	Recruiting	REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS	18	China	clinicaltrials.gov
May 28, 2026	NCT07611747	Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)	Instituto de Investigación Marqués de Valdecilla	Phase 4	Recruiting	Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Axial Spondy, Systemic Lupus Erythematosus (SLE), Caridovascular...	1,944	Spain	clinicaltrials.gov
May 27, 2026	NCT07607964	A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous...	AbbVie	Phase 1	Recruiting	Systemic Lupus Erythematosus, Rheumatoid Arthritis	30	Japan, United States	clinicaltrials.gov
May 20, 2026	NCT07598396	A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis	Hoffmann-La Roche	Phase 2	Recruiting	Lupus, Systemic Lupus Erythematosus, Lupus Nephritis	30	Argentina, Brazil, Colombia, Italy, Mexico, South Africa	clinicaltrials.gov
May 19, 2026	NCT07596680	CD19/BCMA-Targeted Universal CAR-T Cell Injection for the Treatment of Autoimmune Diseases	Nanjing Bioheng Biotech Co., Ltd.	Early phase 1	Not yet recruiting	SLE - Systemic Lupus Erythematosus, Systemic Sclerosis, ANCA Associated Vasculitis, Idiopathic Inflammatory Myopathies...	30	China	clinicaltrials.gov
May 13, 2026	NCT07583030	A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune Diseases	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Early phase 1	Withdrawn	Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE), Relapsed/Refractory IgG4-Related Disease (r/r IgG4-RD)...	0	China	clinicaltrials.gov
May 8, 2026	NCT07575347	Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)	Stefan Lujinschi	Observational	Recruiting	Periodontal Disease, Periodontitis, CKD, Chronic Kidney Disease, Alport Syndrome, Fabry Disease, Lupus or SLE, Tuberous...	100	Romania	clinicaltrials.gov
May 6, 2026	NCT07570862	A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis	Fate Therapeutics	Phase 2	Recruiting	Lupus Nephritis, Systemic Lupus Erythematosus, SLE - Systemic Lupus Erythematosus, Lupus Nephritis - WHO Class III...	53	United States	clinicaltrials.gov
April 30, 2026	NCT07558850	Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases	The First Affiliated Hospital with Nanjing Medical University	Not applicable	Recruiting	Rheumatoid Arthritis, Dermatomyositis, Systemic Lupus Erythematosus, Systemic Sclerosis	72	China	clinicaltrials.gov
April 29, 2026	NCT07555626	Mediterranean Diet and Gut Microbiota in Children With Systemic Lupus Erythematosus	TC Erciyes University	Not applicable	Not yet recruiting	Systemic Lupus Erythematosus (SLE)	60	Turkey (Türkiye)	clinicaltrials.gov
April 22, 2026	NCT07544225	Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic...	Gustave Roussy, Cancer Campus, Grand Paris	Phase 1	Not yet recruiting	Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Sjogren's Disease With Dry Eyes, Systemic Sclerosis...	6	France	clinicaltrials.gov
April 20, 2026	NCT07538154	A Clinica Study of SCTC21C in Participants With Systemic Lupus Erythematosus	Sinocelltech Ltd.	Phase 1/2	Not yet recruiting	Systemic Lupus Erythematosus (SLE)	159		clinicaltrials.gov
April 13, 2026	NCT07526350	MTS109 in Patients With Refractory Autoimmune Diseases	Shanghai Changzheng Hospital	Early phase 1	Recruiting	Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies, Systemic Sclerosis (SSc), ANCA-Associated Vasculitis...	15	China	clinicaltrials.gov
April 13, 2026	NCT07523542	SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus	Beijing Biotech	Phase 1/2	Recruiting	REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS, Lupus Nephritis	24	China	clinicaltrials.gov
April 13, 2026	NCT07523282	Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases	Shenzhen MagicRNA Biotechnology Co., Ltd	Phase 1	Not yet recruiting	Autoimmune Disease, Systemic Lupus Erythematosus, Systemic Sclerosis (SSc)	12	China	clinicaltrials.gov
April 8, 2026	NCT07517536	CHT105 for the Treatment of Refractory Lupus Nephritis	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	Not applicable	Enrolling by invitation	Systemic Lupus Erythematosus, Lupus Nephritis	14	China	clinicaltrials.gov
April 8, 2026	NCT07516639	First-in-Human Study of ISH0613: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics	SUNHO（China）BioPharmaceutical CO., Ltd.	Phase 1	Not yet recruiting	Healthy Subjects (HS), SLE (Systemic Lupus)	26	China	clinicaltrials.gov
April 7, 2026	NCT07515638	Immun4Cure Cohort of Autoimmune Diseases	University Hospital, Montpellier	Observational	Recruiting	Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis, Healthy Adult Volunteers	500	France	clinicaltrials.gov
April 7, 2026	NCT07515014	A Study of E6742 in Participants With Systemic Lupus Erythematosus	Eisai Co., Ltd.	Phase 2	Recruiting	Systemic Lupus Erythematosus	256	China, Japan, South Korea, Taiwan	clinicaltrials.gov
April 6, 2026	NCT07512947	Study of YKST02 Alone or in Combination With YK012 in Patients With Active or Refractory Systemic Lupus Erythematosus	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Phase 1	Not yet recruiting	System Lupus Erythematosus(SLE)	30	China	clinicaltrials.gov
April 3, 2026	NCT07509892	A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Phase 2	Recruiting	Systemic Lupus Erythematosus	198	China	clinicaltrials.gov
March 25, 2026	NCT07493655	Therapeutic Drug Monitoring of Mycophenolate Mofetil in Lupus Nephritis	Federal University of Maranhao	Not applicable	Not yet recruiting	Systemic Lupus Erythematosus, Lupus Nephritis, Drug Monitoring, Mycophenolic Acid	100	Brazil	clinicaltrials.gov
March 24, 2026	NCT07490275	Allogeneic CD19/BCMA-Targeted CAR-γδT Cell Therapy: Safety and Preliminary Pharmacodynamics in Relapsed/Refractory Autoimmune Diseases	Institute of Hematology & Blood Diseases Hospital, China	Phase 1	Not yet recruiting	Refractory/Relapsed Systemic Lupus Erythematosus, Refractory / Relapsed / Progressive Systemic Sclerosis, Refractory /...	9		clinicaltrials.gov
March 24, 2026	NCT07490041	Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric...	The Children's Hospital of Zhejiang University School of Medicine	Early phase 1	Recruiting	Rheumatic Diseases, Pediatric Rheumatological Condition (i.e., Arthritis, SLE, Kawasaki's Disaese), Systemic Lupus...	36	China	clinicaltrials.gov
March 19, 2026	NCT07483541	Identification of Modifiable Sleep-related Factors in Patients With Systemic Lupus Erythematosus.	Investigación en Hemofilia y Fisioterapia	Observational	Not yet recruiting	Lupus Erythematosus	250	Spain	clinicaltrials.gov
March 19, 2026	NCT07483346	IASO-782 in Systemic Lupus Erythematosus	Shanghai IASO Biotechnology Co., Ltd	Phase 1	Recruiting	SLE - Systemic Lupus Erythematosus	20	China	clinicaltrials.gov
March 18, 2026	NCT07481214	Lupus Walking Intervention to Address Fatigue/Quality of Life	University of California, San Francisco	Not applicable	Completed	System Lupus Erythematosus(SLE)	101	United States	clinicaltrials.gov
March 13, 2026	NCT07470151	Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Not applicable	Recruiting	System Lupus Erythematosus(SLE), Scleroderma, Myasthenia Gravis (MG)	12	China	clinicaltrials.gov
March 4, 2026	NCT07447986	To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus Erythematosus	Hangzhou Sumgen Biotech Co., Ltd.	Phase 2	Recruiting	Systemic Lupus Erythematosus (SLE)	120	China	clinicaltrials.gov
March 2, 2026	NCT07444307	A Clinical Study of Dual-Target, Universal CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus	Hangzhou Qihan Biotech Co., Ltd.	Phase 1	Recruiting	Systemic Lupus Erythematosus (SLE)	18	China	clinicaltrials.gov
February 27, 2026	NCT07439029	YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases	Children's Hospital of Fudan University	Phase 1	Not yet recruiting	Systemic Lupus Erythematosus (SLE), Diffuse Systemic Sclerosis, Idiopathic Inflammatory Myopathies (IIMs), ANCA...	12	China	clinicaltrials.gov
February 27, 2026	NCT07438496	A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus	Janssen Research & Development, LLC	Phase 3	Recruiting	Lupus Erythematosus, Systemic	600	Argentina, Australia, Brazil, Bulgaria, China, Czechia, Denmark, Finland...	clinicaltrials.gov
February 25, 2026	NCT07432334	CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus	Vinmec Research Institute of Stem Cell and Gene Technology	Phase 1	Recruiting	Refractory Systemic Lupus Erythematosus	8	Vietnam	clinicaltrials.gov
February 25, 2026	NCT07431775	Saphnelo Use in Females of Child-bearing Potential	AstraZeneca	Observational	Not yet recruiting	Systemic Lupus Erythematosus	26,000,000		clinicaltrials.gov
February 24, 2026	NCT07430306	A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus...	AstraZeneca	Phase 3	Recruiting	Systemic Lupus Erythematosus	245	Canada, France, Germany, Italy, Mexico, Poland, Spain, Taiwan, United States	clinicaltrials.gov
February 23, 2026	NCT07425730	Early Myocardial Dysfunction Helps Identify Severe Refractory Pediatric Lupus	Shanghai Jiao Tong University School of Medicine	Observational	Recruiting	Systemic Lupus Erythematosus (SLE)	60	China	clinicaltrials.gov
February 20, 2026	NCT07424261	NIS to Examine Disease Activity in SLE Patients Treated With Subcutaneous Anifrolumab in Routine Care	AstraZeneca	Observational	Recruiting	Lupus Erythematosus, Systemic	125	Germany	clinicaltrials.gov
February 17, 2026	NCT07413341	A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases	Therorna	Phase 1	Recruiting	Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome (SS), Systemic Sclerosis (SSc), Inflammatory Myopathy, ANCA...	12	China	clinicaltrials.gov
February 13, 2026	NCT07410377	UCAR T-cell Therapy Targeting CD19/ BCMA(QT-019C) in Patients With Relapse/ Refractory Autoimmune Diseases	The Affiliated Hospital of Xuzhou Medical University	Early phase 1	Withdrawn	Systemic Lupus Erythematosus, Inflammatory Myopathy	0	China	clinicaltrials.gov
February 13, 2026	NCT07409181	A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)	Boehringer Ingelheim	Phase 2	Recruiting	Systemic Lupus Erythematosus	405	Argentina, Australia, Brazil, Bulgaria, China, Colombia, Croatia, Germany...	clinicaltrials.gov
February 13, 2026	NCT07408908	Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of ACT100 in Healthy Participants..	Xiamen Amoytop Biotech Co., Ltd.	Phase 1	Not yet recruiting	Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus	48		clinicaltrials.gov
February 12, 2026	NCT07405970	A Phase 3 Clinical Study of MIL62 in Systemic Lupus Erythematosus	Beijing Mabworks Biotech Co., Ltd.	Phase 3	Recruiting	Systemic Lupus Erythematosus	316	China	clinicaltrials.gov
February 11, 2026	NCT07403097	Study of CD19 CAR-T Therapy for Refractory SLE	Chongqing Precision Biotech Co., Ltd	Phase 1	Recruiting	Systemic Lupus Erythematosus	18	China	clinicaltrials.gov
February 10, 2026	NCT07398885	Assessing the Impact of Herbal Supplement on Fatigue and Disease Activity in SLE: Results From an 8-Week Randomized Trial	University Tunis El Manar	Not applicable	Completed	System; Lupus Erythematosus	59	Tunisia	clinicaltrials.gov
February 9, 2026	NCT07397728	" TREX1 Gene Mutations and Their Role in Systemic Lupus Erythematosus	South Valley University	Observational	Recruiting	Systemic Lupus Erythematosus	90	Egypt	clinicaltrials.gov
February 6, 2026	NCT07394361	The Effect of Clinical Pilates Training on Fatigue, Emotional State, Functional Capacity, Sleep and Quality of Life in Women With Systemic...	Emir İbrahim IŞIK	Not applicable	Enrolling by invitation	Lupus Erythematosus, Systemic	30	Turkey (Türkiye)	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
AstraZeneca	16	August 7, 2026
Assiut University	10	October 5, 2026
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	7	May 13, 2026
The Children's Hospital of Zhejiang University School of Medicine	6	June 29, 2026
China Immunotech (Beijing) Biotechnology Co., Ltd.	5	November 19, 2025
Bristol-Myers Squibb	4	October 14, 2026
Assistance Publique - Hôpitaux de Paris	4	July 23, 2026
Chinese SLE Treatment And Research Group	4	June 18, 2026
Peking University People's Hospital	4	June 1, 2026
Institute of Hematology & Blood Diseases Hospital, China	4	March 24, 2026
Chongqing Precision Biotech Co., Ltd	4	February 11, 2026
Tongji Hospital	4	January 14, 2026
Universitas Sriwijaya	4	July 24, 2025
EMD Serono Research & Development Institute, Inc.	3	September 25, 2026
NYU Langone Health	3	September 16, 2026
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	3	August 5, 2026
Sohag University	3	January 20, 2026
CytoCares Inc	3	September 26, 2025
Seoul National University Hospital	2	October 2, 2026
Fate Therapeutics	2	September 2, 2026

By phase

Phase	New trials	Latest
Phase 1	79	November 6, 2026
Observational	66	October 29, 2026
Not applicable	43	November 3, 2026
Phase 2	27	September 28, 2026
Early phase 1	25	August 5, 2026
Phase 1/2	20	September 2, 2026
Phase 3	10	September 25, 2026
Phase 4	7	August 12, 2026
Phase 2/3	2	July 23, 2026

By country

Country	New trials	Latest
China	118	October 28, 2026
United States	54	October 14, 2026
Spain	24	September 2, 2026
France	23	October 14, 2026
Germany	16	October 14, 2026
Brazil	16	June 22, 2026
Australia	15	August 21, 2026
Italy	15	June 5, 2026
Japan	12	June 5, 2026
United Kingdom	11	November 3, 2026
Poland	10	October 14, 2026
Belgium	9	October 14, 2026
Romania	9	May 8, 2026
Taiwan	9	April 7, 2026
Canada	9	February 24, 2026
South Korea	8	October 2, 2026
Egypt	8	July 23, 2026
Israel	8	June 5, 2026
Bulgaria	7	February 27, 2026
Netherlands	6	October 14, 2026
Turkey (Türkiye)	6	October 9, 2026
Argentina	6	May 20, 2026
Mexico	5	July 1, 2026
South Africa	5	May 20, 2026
Indonesia	5	September 19, 2025

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.